Treating Parkinson's Disease Through Transplantation of Autologous Stem Cell-Derived Dopaminergic Neurons
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Jeffrey S. Schweitzer, MD, PhD
- Study ID
- NCT06687837
- Phase
- PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- autologous dopaminergic cell implantation — BIOLOGICALDopaminergic progenitor cells derived from autologous induced pluripotent stem cells will be injected into the brain in two cohorts of Parkinson's patients, one receiving low dose and the other high dose (4 and 8 million cells, respectively)
Study Details
The goal of this clinical trial is to assess the safety and tolerability of the surgical transplantation of dopaminergic progenitor cells into the brains of participants with Parkinson's disease. The transplanted dopaminergic cells will be derived from the participant's own skin cells.
Key Dates
- Start date
- Apr 29, 2025
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 8 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: Low dose administration4 million autologous dopaminergic cells will be implanted into the putamen on each side of the brain
- Experimental: High dose administration8 million autologous dopaminergic cells will be implanted into the putamen on each side of the brain
Primary Outcome Measure
Safety and Tolerability [ Time Frame: 2 years from time of implantation ]
Central Contacts
- Jeffrey S Schweitzer, MD, PhD6177261799
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- Natural History Study of SynucleinopathiesRecruiting · NYU Langone Health · Boston, Massachusetts
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- Study in Parkinson Disease of ExerciseRecruiting · Northwestern University · Birmingham, Alabama